BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
Credit Suisse maintains outperform on Torrent Pharmaceuticals
We remain positive on Torrent. Weak US pipeline for Torrent is a concern. High R&D spend will address weak US markets. Dahej plant commissioning will be a key trigger for the company.